Latest return on equity
Cullinan Therapeutics Return on equity
Direct answer
Cullinan Therapeutics's return on equity is -50.3%.
The verified market snapshot reports -50.3%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 11, 2026.
Get free Cullinan Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -50.3%
Explore related company data
View Cullinan Therapeutics's market capitalizationView Cullinan Therapeutics's price-to-book ratioView Cullinan Therapeutics's dividend yieldView Cullinan Therapeutics's 52-week price rangeView Cullinan Therapeutics's profit marginView Cullinan Therapeutics's debt-to-equity ratioView all Cullinan Therapeutics key metricsReturn to Cullinan Therapeutics profile